Infectious complications related to radiofrequency ablation of liver tumors: The role of antibiotics

<h4>Background and aim</h4> Prophylactic administration of antibiotics within 24 hours of surgery is recommended to reduce the risk of infection. We conducted a prospective study to compare the efficacy of single administration of antibiotics with a historical control of continuous admin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ryo Nakagomi, Ryosuke Tateishi, Shintaro Mikami, Taijiro Wake, Mizuki Nishibatake Kinoshita, Takuma Nakatsuka, Tatsuya Minami, Masaya Sato, Koji Uchino, Kenichiro Enooku, Hayato Nakagawa, Yoshinari Asaoka, Shuichiro Shiina, Kazuhiko Koike
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ecc87d01ec004fa0ad29dd8900796aac
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ecc87d01ec004fa0ad29dd8900796aac
record_format dspace
spelling oai:doaj.org-article:ecc87d01ec004fa0ad29dd8900796aac2021-11-25T06:19:28ZInfectious complications related to radiofrequency ablation of liver tumors: The role of antibiotics1932-6203https://doaj.org/article/ecc87d01ec004fa0ad29dd8900796aac2021-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604344/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background and aim</h4> Prophylactic administration of antibiotics within 24 hours of surgery is recommended to reduce the risk of infection. We conducted a prospective study to compare the efficacy of single administration of antibiotics with a historical control of continuous administration of antibiotics for radiofrequency ablation (RFA) of malignant liver tumors. <h4>Methods</h4> Between February 1, 1999 and November 30, 2010, a total of 6,763 RFA treatments were performed in 2,355 patients, using a protocol with continuous administration of prophylactic antibiotics. On December 1, 2010, we began using a revised protocol with a single administration of prophylactic antibiotics, while continuing to use the old continuous administration protocol for patients who declined the new protocol. Interim analysis was performed to assess the safety of the single administration protocol. Thereafter, from April 1, 2012, all patients were treated using the new protocol. Risk factors for infectious complications of RFA were assessed using logistic regression. <h4>Results</h4> From December 2010 to March 2012, 766 RFA treatments were performed in 663 patients using the new antibiotic protocol. Infectious complications were observed following 4 of these treatments (0.52%). As the upper limit of the confidence interval (CI) resulting from a one-sided binomial test was exactly the prespecified limit of 1.0%, from April 2012 onwards, we treated all patients using the new protocol with single administration of prophylactic antibiotics. A total of 3,547 RFA treatments were performed using the single administration protocol. Univariable logistic regression indicated that prior transcatheter arterial chemoembolization (TACE) and maximal tumor diameter were significant risk factors for infectious complications (P = 0.04 and P < 0.001, respectively). Multivariable analysis indicated that the adjusted hazard ratio of single vs. continuous administration of antibiotics was 1.20 (95% CI: 0.53–2.75; P = 0.66). <h4>Conclusions</h4> The rate of infectious complications related to RFA was acceptably low. Single administration of prophylactic antibiotics did not significantly increase the rate of infectious complications related to RFA, compared with a more intensive antibiotic protocol.Ryo NakagomiRyosuke TateishiShintaro MikamiTaijiro WakeMizuki Nishibatake KinoshitaTakuma NakatsukaTatsuya MinamiMasaya SatoKoji UchinoKenichiro EnookuHayato NakagawaYoshinari AsaokaShuichiro ShiinaKazuhiko KoikePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ryo Nakagomi
Ryosuke Tateishi
Shintaro Mikami
Taijiro Wake
Mizuki Nishibatake Kinoshita
Takuma Nakatsuka
Tatsuya Minami
Masaya Sato
Koji Uchino
Kenichiro Enooku
Hayato Nakagawa
Yoshinari Asaoka
Shuichiro Shiina
Kazuhiko Koike
Infectious complications related to radiofrequency ablation of liver tumors: The role of antibiotics
description <h4>Background and aim</h4> Prophylactic administration of antibiotics within 24 hours of surgery is recommended to reduce the risk of infection. We conducted a prospective study to compare the efficacy of single administration of antibiotics with a historical control of continuous administration of antibiotics for radiofrequency ablation (RFA) of malignant liver tumors. <h4>Methods</h4> Between February 1, 1999 and November 30, 2010, a total of 6,763 RFA treatments were performed in 2,355 patients, using a protocol with continuous administration of prophylactic antibiotics. On December 1, 2010, we began using a revised protocol with a single administration of prophylactic antibiotics, while continuing to use the old continuous administration protocol for patients who declined the new protocol. Interim analysis was performed to assess the safety of the single administration protocol. Thereafter, from April 1, 2012, all patients were treated using the new protocol. Risk factors for infectious complications of RFA were assessed using logistic regression. <h4>Results</h4> From December 2010 to March 2012, 766 RFA treatments were performed in 663 patients using the new antibiotic protocol. Infectious complications were observed following 4 of these treatments (0.52%). As the upper limit of the confidence interval (CI) resulting from a one-sided binomial test was exactly the prespecified limit of 1.0%, from April 2012 onwards, we treated all patients using the new protocol with single administration of prophylactic antibiotics. A total of 3,547 RFA treatments were performed using the single administration protocol. Univariable logistic regression indicated that prior transcatheter arterial chemoembolization (TACE) and maximal tumor diameter were significant risk factors for infectious complications (P = 0.04 and P < 0.001, respectively). Multivariable analysis indicated that the adjusted hazard ratio of single vs. continuous administration of antibiotics was 1.20 (95% CI: 0.53–2.75; P = 0.66). <h4>Conclusions</h4> The rate of infectious complications related to RFA was acceptably low. Single administration of prophylactic antibiotics did not significantly increase the rate of infectious complications related to RFA, compared with a more intensive antibiotic protocol.
format article
author Ryo Nakagomi
Ryosuke Tateishi
Shintaro Mikami
Taijiro Wake
Mizuki Nishibatake Kinoshita
Takuma Nakatsuka
Tatsuya Minami
Masaya Sato
Koji Uchino
Kenichiro Enooku
Hayato Nakagawa
Yoshinari Asaoka
Shuichiro Shiina
Kazuhiko Koike
author_facet Ryo Nakagomi
Ryosuke Tateishi
Shintaro Mikami
Taijiro Wake
Mizuki Nishibatake Kinoshita
Takuma Nakatsuka
Tatsuya Minami
Masaya Sato
Koji Uchino
Kenichiro Enooku
Hayato Nakagawa
Yoshinari Asaoka
Shuichiro Shiina
Kazuhiko Koike
author_sort Ryo Nakagomi
title Infectious complications related to radiofrequency ablation of liver tumors: The role of antibiotics
title_short Infectious complications related to radiofrequency ablation of liver tumors: The role of antibiotics
title_full Infectious complications related to radiofrequency ablation of liver tumors: The role of antibiotics
title_fullStr Infectious complications related to radiofrequency ablation of liver tumors: The role of antibiotics
title_full_unstemmed Infectious complications related to radiofrequency ablation of liver tumors: The role of antibiotics
title_sort infectious complications related to radiofrequency ablation of liver tumors: the role of antibiotics
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/ecc87d01ec004fa0ad29dd8900796aac
work_keys_str_mv AT ryonakagomi infectiouscomplicationsrelatedtoradiofrequencyablationoflivertumorstheroleofantibiotics
AT ryosuketateishi infectiouscomplicationsrelatedtoradiofrequencyablationoflivertumorstheroleofantibiotics
AT shintaromikami infectiouscomplicationsrelatedtoradiofrequencyablationoflivertumorstheroleofantibiotics
AT taijirowake infectiouscomplicationsrelatedtoradiofrequencyablationoflivertumorstheroleofantibiotics
AT mizukinishibatakekinoshita infectiouscomplicationsrelatedtoradiofrequencyablationoflivertumorstheroleofantibiotics
AT takumanakatsuka infectiouscomplicationsrelatedtoradiofrequencyablationoflivertumorstheroleofantibiotics
AT tatsuyaminami infectiouscomplicationsrelatedtoradiofrequencyablationoflivertumorstheroleofantibiotics
AT masayasato infectiouscomplicationsrelatedtoradiofrequencyablationoflivertumorstheroleofantibiotics
AT kojiuchino infectiouscomplicationsrelatedtoradiofrequencyablationoflivertumorstheroleofantibiotics
AT kenichiroenooku infectiouscomplicationsrelatedtoradiofrequencyablationoflivertumorstheroleofantibiotics
AT hayatonakagawa infectiouscomplicationsrelatedtoradiofrequencyablationoflivertumorstheroleofantibiotics
AT yoshinariasaoka infectiouscomplicationsrelatedtoradiofrequencyablationoflivertumorstheroleofantibiotics
AT shuichiroshiina infectiouscomplicationsrelatedtoradiofrequencyablationoflivertumorstheroleofantibiotics
AT kazuhikokoike infectiouscomplicationsrelatedtoradiofrequencyablationoflivertumorstheroleofantibiotics
_version_ 1718413899329437696